SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The turnover for the December 2023 quarter moved up 53.70% to Rs. 973.36 millions as compared to Rs. 633.27 millions during the year-ago period.A humble growth in net profit of 17.37% reported in the quarter ended December 2023 to Rs. 5.00  millions from Rs. 4.26 millions.Operating profit surged to 69.78 millions from the corresponding previous quarter of 66.04 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 973.36 633.27 53.70 2663.60 2811.48 -5.26 3722.53 4510.68 -17.47
Other Income 0.02 1.35 -98.52 0.51 1.43 -64.34 4.36 0.89 389.89
PBIDT 69.78 66.04 5.66 57.46 254.22 -77.40 259.54 491.45 -47.19
Interest 33.10 32.18 2.86 99.67 93.18 6.97 127.51 111.62 14.24
PBDT 36.68 33.86 8.33 -42.21 161.04 -126.21 132.03 379.83 -65.24
Depreciation 36.24 28.83 25.70 107.73 82.39 30.76 109.89 102.49 7.22
PBT 0.44 5.03 -91.25 -149.94 78.65 -290.64 22.14 277.34 -92.02
TAX -4.56 0.77 -692.21 -24.00 22.07 -208.74 9.44 80.76 -88.31
Deferred Tax -3.50 2.00 -275.00 -24.00 -0.50 4700.00 9.70 -7.32 -232.51
PAT 5.00 4.26 17.37 -125.94 56.58 -322.59 12.70 196.58 -93.54
Equity 158.28 158.28 0.00 158.28 158.28 0.00 158.28 158.28 0.00
PBIDTM(%) 7.17 10.43 -31.26 2.16 9.04 -76.14 6.97 10.90 -36.01

Mangalam Drugs&Org. Share Price

29.75 0.02 (0.07%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×